Results 101 to 110 of about 1,901 (143)
Fanconi syndrome induced by zoledronic acid: Two case reports. [PDF]
Medicine (Baltimore)Chen Y +5 more
europepmc +1 more source
Prodrug strategies in developing antiviral nucleoside analogs. [PDF]
RSC Med ChemSuresh RR +15 more
europepmc +1 more source
QuEChERS and UPLC-MS/MS-Based Quantification of Human Plasma of Eight Nucleoside Reverse Transcriptase Inhibitors and Platinum Anticancer Drugs for Hepatocellular Carcinoma. [PDF]
MoleculesLiu Y +5 more
europepmc +1 more source
FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry. [PDF]
Front PharmacolSingh M +3 more
europepmc +1 more source
Analysis of Clinical Characteristics and Treatment Efficacy in the Korean Hepatitis B Cohort. [PDF]
Public Health Wkly RepKim T +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 1999
Adefovir dipivoxil is an ester prodrug of the nucleoside reverse transcriptase inhibitor adefovir (PMEA), the prototype compound of the acyclic nucleoside phosphonates. It has better oral bioavailability than the parent compound. Adefovir dipivoxil 120mg once daily significantly reduced viral load compared with placebo when added to standard ...
S, Noble, K L, Goa
+5 more sources
Adefovir dipivoxil is an ester prodrug of the nucleoside reverse transcriptase inhibitor adefovir (PMEA), the prototype compound of the acyclic nucleoside phosphonates. It has better oral bioavailability than the parent compound. Adefovir dipivoxil 120mg once daily significantly reduced viral load compared with placebo when added to standard ...
S, Noble, K L, Goa
+5 more sources
Drugs of Today, 2003
In chronic hepatitis B therapy there are new and exciting developments in antivirals such as nucleotide analogues. Adefovir is the latest drug approved for therapy of chronic hepatitis B. This agent has a potent in vitro and in vivo effect against herpes virus, retroviruses and hepadnaviruses.
María, Buti, Rafael, Esteban
openaire +2 more sources
In chronic hepatitis B therapy there are new and exciting developments in antivirals such as nucleotide analogues. Adefovir is the latest drug approved for therapy of chronic hepatitis B. This agent has a potent in vitro and in vivo effect against herpes virus, retroviruses and hepadnaviruses.
María, Buti, Rafael, Esteban
openaire +2 more sources